| Literature DB >> 27872149 |
Kunitoshi Chiba1, Jacob M Vogan1, Robert A Wu1, Manraj S Gill1, Xiaozhu Zhang1, Kathleen Collins1, Dirk Hockemeyer2.
Abstract
Telomerase action at telomeres is essential for the immortal phenotype of stem cells and the aberrant proliferative potential of cancer cells. Insufficient telomere maintenance can cause stem cell and tissue failure syndromes, while increased telomerase levels are associated with tumorigenesis. Both pathologies can arise from only small perturbation of telomerase function. To analyze telomerase at its low endogenous expression level, we genetically engineered human pluripotent stem cells (hPSCs) to express various N-terminal fusion proteins of the telomerase reverse transcriptase from its endogenous locus. Using this approach, we found that these modifications can perturb telomerase function in hPSCs and cancer cells, resulting in telomere length defects. Biochemical analysis suggests that this defect is multileveled, including changes in expression and activity. These findings highlight the unknown complexity of telomerase structural requirements for expression and function in vivo.Entities:
Keywords: CRISPR/Cas9; embryonic stem cells; genome editing; pluripotent stem cells; telomerase; telomeres
Mesh:
Substances:
Year: 2017 PMID: 27872149 PMCID: PMC5247607 DOI: 10.1128/MCB.00541-16
Source DB: PubMed Journal: Mol Cell Biol ISSN: 0270-7306 Impact factor: 4.272